Key Market Indicators
Swiss insulin imports are forecast to dip 6.4% year-on-year, from $19.1 million in 2021 to $12.6 million in 2026. Since 1993, the demand for insulin in Switzerland has decreased by an average of 14.7% annually. Meanwhile, Swiss insulin exports surged 535.7% year-on-year in 2019, reaching $4.75 million from $746.68 in 2018. The country ranked 57th in the world for insulin exports in 2019, behind Malta, France, Italy and China. Since 1993, Swiss insulin supply has grown by 74.4% on average each year.
